Avalo Therapeutics, Inc.

Avalo Therapeutics, Inc.

AVTX
Avalo Therapeutics, Inc.US flagNASDAQ Capital Market
18.82
USD
+0.61
- -
212.56MMarket Cap

Avalo Therapeutics, Inc. (AVTX) Stock Split History

Learn about Avalo Therapeutics, Inc.'s most recent 1-for-240 basis stock split on December 29, 2023. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Avalo Therapeutics, Inc.'s most recent stock split

Split Date: 2023-12-29
Split Ratio: 1:240
Price Before Split: $0.04
Price After Split: $0.00

Developer API

Get AVTX split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/AVTX

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 240.00 times fewer shares (a 1:240 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Avalo Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-12-291:240Yes$0.04$0.00
2022-07-081:12Yes$0.43$0.04

About Avalo Therapeutics, Inc.

Company overview and industry information

Avalo Therapeutics, Inc. (AVTX) operates in the Biotechnology industry. The recent 1-for-240 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Avalo Therapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.